Sign In
Buy OPCH
$23.03
+0.570 (+2.54%)
At Close: Jul 31, 2026
Best Growth Stocks to Buy for August 11th
10:47am, Friday, 11'th Aug 2023
OPCH, PCRFY and BEKE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 11, 2023.
Best Growth Stocks to Buy for August 4th
07:32am, Friday, 04'th Aug 2023
TOL, CWCO and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2023.
Time to Add These 5 Relative Price Strength Stocks
08:57am, Wednesday, 02'nd Aug 2023
COOP, MAS, OPCH, SOI and PHM are five stocks with explosive relative price strength.
Option Care Health, Inc. (OPCH) Q2 2023 Earnings Call Transcript
01:45pm, Thursday, 27'th Jul 2023
Option Care Health, Inc. (NASDAQ:OPCH ) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Mike Shapiro – Chief Financial Officer John Rademacher – Chief Executive Offi
OPCH or USPH: Which Is the Better Value Stock Right Now?
12:52pm, Wednesday, 19'th Jul 2023
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or U.S. Physical Therapy (USPH). But which of these two stocks offe
Option Care Health to Announce Second Quarter 2023 Financial Results and Host Conference Call
08:00am, Thursday, 06'th Jul 2023
BANNOCKBURN, Ill., July 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion se
Option Care (OPCH) Moves 5.2% Higher: Will This Strength Last?
09:48am, Tuesday, 27'th Jun 2023
Option Care (OPCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the
Option Care (OPCH) Surges 6.3%: Is This an Indication of Further Gains?
09:59am, Tuesday, 06'th Jun 2023
Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Amedisys received unsolicited buyout bid from Optum that could be ‘superior' to deal with Option Care Health
08:39am, Monday, 05'th Jun 2023
Amedisys Inc. AMED, +3.64% disclosed Monday that it had received an unsolicited cash buyout bid for $100 a share from Optum, which the at-home healthcare services company believes could be considered
Option Care Health to Participate in Upcoming Investor Conferences
04:05pm, Thursday, 18'th May 2023
BANNOCKBURN, Ill., May 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site inf
Option Care Health to Present at the BofA Securities Health Care Conference
04:05pm, Friday, 05'th May 2023
BANNOCKBURN, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site inf
Option Care (OPCH) Q1 Earnings and Revenues Top Estimates
09:15pm, Wednesday, 03'rd May 2023
Option Care (OPCH) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.17 per share a year ago.
Option Care Health to Announce First Quarter 2023 Financial Results and Host Conference Call
04:05pm, Tuesday, 18'th Apr 2023
BANNOCKBURN, Ill., April 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion s
Option Care Health, Inc. (OPCH) Q4 2022 Earnings Call Transcript
04:30pm, Thursday, 23'rd Feb 2023
Option Care Health, Inc. (NASDAQ:OPCH ) Q4 2022 Earnings Conference Call February 23, 2022 8:30 AM ET Company Participants Michael Shapiro - CFO & SVP John Rademacher - CEO, President & Director Confe
Option Care (OPCH) Surpasses Q4 Earnings and Revenue Estimates
10:32am, Thursday, 23'rd Feb 2023
Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 0.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
